Phaarmasia Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Phaarmasia Ltd (PHAARMASIALTD) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads PHAARMASIALTD vs SUNPHARMA on 9 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

3.80
P/E ratio
40.40
3.78
P/B ratio
5.57
0.00%
Dividend yield
0.83%
₹-2.33
EPS
₹47.84

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

12.80%
Return on equity
16.00%
-16.00%
Return on capital
21.00%
-8.00%
EBITDA margin
30.00%
-8.33%
Net margin
19.69%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

20.47%
Revenue CAGR (3Y)
10.03%
Profit CAGR (3Y)
10.57%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹68 Cr
Market cap
₹4.64L Cr
₹24 Cr
Revenue
₹58,462 Cr
₹-2 Cr
Net profit
₹11,509 Cr
0.05
Debt / equity
0.06
Phaarmasia Ltd
  • + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has delivered good profit growth of 44.8% CAGR over last 5 years", "Debtor days have improved from 60.8 to 39.7 days."]
  • ["Stock is trading at 2.95 times its book value", "Company has a low return on equity of -0.39% over last 3 years.", "Earnings include an other income of Rs.20.0 Cr.", "Working capital days have increased from -17.3 days to 62.1 days"]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Phaarmasia Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.